Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by tuesdaynightridon Nov 10, 2015 12:14pm

150 Views

Post# 24277411

RE:News

Ok, I just read the NR from the used car salesman.
Is this true? I mean the part about the FDA.

"Theralase is awaiting Health Canada and Food and Drug Administration (FDA) approval of its TLC-3000 anti-cancer technology to commence enrolling patients in late 4Q2015 in either Canada, the United States of America or both to determine the safety, tolerability and efficacy of this technology in the destruction of Non-Muscle Invasive Bladder Cancer."

I'd be shocked if Rog said something that wasn't true!

Bullboard Posts

Rising miner increases graphite price, restarts Québec mill